Company / Cost of Revenue
INTERPACE BIOSCIENCES, INC. Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$14.6M
FY2025
5-year range
$7.3M / $17.0M
FY2021-FY2025
Trend
-14.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cost of Revenue has fluctuated over the past 10 years, ranging from $7M in FY2016 to $22M in FY2020.
Based on SEC 10-K filings.
$15M in FY2025 with a 5-year CAGR of -7.6%.
Increased from $7M to $15M over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +2.4%
- 5-Year CAGR
- -7.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -7.6%, indicating a declining trend.
- In FY2025, cost of revenue decreased 14.1% year-over-year.
- Peak cost of revenue was recorded in FY2020.
- Lowest cost of revenue in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -2.84 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.6M | -14.1% |
| FY2024 | $17.0M | +131.6% |
| FY2023 | $7.3M | -46.1% |
| FY2022 | $13.6M | -4.9% |
| FY2021 | $14.3M | -34.0% |
| FY2020 | $21.7M | +36.4% |
| FY2019 | $15.9M | +55.8% |
| FY2018 | $10.2M | +38.6% |
| FY2017 | $7.4M | +10.8% |
| FY2016 | $6.6M | -3.9% |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026